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ABSTRACT 
 
Cell Toxicity and Uptake of RRR-alpha-Tocopheryl Polyethylene Glycol 1000 Succinate 
(TPGS) by Various Cell Lines In Vitro 
 
by 
Christelle Komguem Kamga 
 
This research focused on investigating and comparing the cytotoxicity and cellular uptake 
of RRR-alpha-tocopheryl polyethylene glycol succinate (TPGS) with that of alpha-
tocopheryl succinate (α-TS). Both TPGS and α-TS are water-soluble forms of vitamin E 
with important clinical applications. Cytotoxicity assays with RAW 264.7 and LNCaP 
cells incubated overnight with TPGS or α-TS at concentrations ≥ 12.4 µM suggest that α-
TS is more cytotoxic than TPGS. Macrophages were found to be more sensitive than 
LNCaP cells when treated with similar concentrations of α-TS. For both cell lines, most 
of the TPGS or α-TS taken up remained esterified after 24 hours. Our results suggest that 
cell death was due to TPGS and/or α-TS and not alpha-tocopherol. A para-
hydroxyanilide of α-TS (p-HATS) that could be used to distinguish between cellular 
TPGS and α-TS was studied. It was found that p-HATS can be detected 
electrochemically and that it is hydrolyzed to α-TOH.  
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CHAPTER 1 
INTRODUCTION 
Vitamin E was labeled the sex vitamin soon after its discovery in 1922 by 
Herbert Evans and Katharine Bishop, because of its important role in mammalian 
reproduction and fertility1, 2.  After its lipophilic components, tocopherols and 
tocotrienols were isolated and characterized, research focused on vitamin Es role as 
antioxidant2.  Vitamin E was shown to inhibit lipid peroxidation triggered by free 
radicals3, 4.  Reactions of the latter with cellular components have been associated with 
the pathophysiology of some malignancies including cancers of the lungs, ovaries5, skin, 
prostate, colon6, stomach, and esophagus.  Alpha-tocopherol, the predominant form of 
vitamin E in human and animal tissues, has been shown to scavenge lipid peroxyl 
radicals, which are the chain-carrying species in lipid peroxidation2, 3, 4.  The antioxidant 
property of vitamin E suggests it might be a potential agent for tumor prevention7, 8, 9.  
In our study, we used RRR-alpha-tocopheryl polyethylene glycol 1000 succinate 
(TPGS), a water-soluble source of alpha-tocopherol for patients with fat malabsorption10. 
In this investigation, TPGS toxicity and uptake by different cell lines was studied in time 
and dose-dependent experiments.  RAW 264.7 macrophage cells were used because they 
contain esterases that can hydrolyze TPGS. Studies were also carried out with androgen-
dependent human prostate cancer cells (LNCAP). 
 
 Vitamin E Compounds 
Natural Forms of Vitamin E 
Vitamin E is a common name used to designate eight natural compounds of two 
types, tocopherols and tocotrienols. As the structures in Figure 1 show, these compounds 
all possess a chroman ring with different substitution patterns of methyl groups at 
positions 5 and 7 of the head group (α−, β−, δ−, γ-), and a 16-carbon side chain1. 
However, while tocopherols have a saturated phytyl side chain with two chiral centers at 
carbons 4 and 8, tocotrienols possess an unsaturated  side chain with double bonds at 
positions 3, 7, and 11. 
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Figure 1. Structures of naturally occurring forms of Vitamin E. Chiral centers are 
indicated by an *.  
 
Of all natural forms, α-tocopherol has the highest biological activity and is the 
predominant form of this vitamin found in human tissues1. It also exists in a synthetic 
form. However, by virtue of the three chiral carbons at positions 2, 4 and 8, the 
synthetic all-racemic-α-tocopherol is a mixture of eight stereoisomers rather than a single 
compound1. The natural configuration of RRR-α-tocopherol is 2R, 4R; 8R.  Chemical 
structures of d-α-tocopherol stereoisomers are given in the appendix. 
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A Special Ester Derivative of Natural Alpha -Tocopherol: TPGS 
Alpha-tocopherol can be esterified by reaction with acids to form α-tocopheryl 
acetate, succinate, linoleate, or nicotinate1. In the body, enzymes called esterases remove 
these acids, liberating the active α-tocopherol.  Further esterification of the acid group of 
RRR-α-tocopheryl succinate by polyethylene glycol 1000 (PEG 1000) produces RRR-α-
tocopheryl polyethylene glycol 1000 succinate (TPGS), whose structure is shown in 
Figure 2. TPGS is amphipatic and, in contrast to other fat-soluble forms of vitamin E, is 
water-soluble and forms its own micelles. This unique property has been used clinically 
to supply Vitamin E to patients with poor production of bile and pancreatic enzymes8. 
 
 
 
Figure 2.  Chemical structure of TPGS. The diester has a polyethylene glycol group 
substituted at the carboxyl group of RRR-α-tocopheryl succinate. PEG stands for 
polyethylene glycol 1000. 
 
TPGS hydrolysis would yield PEG and α-tocopheryl succinate (α-TS), and 
further hydrolysis of α-TS produces α-tocopherol (α-TOH) and succinate (S) as shown in 
equations (1) and (2). Alternatively, α-TOH, S, and PEG could directly be produced from 
TPGS by hydrolysis as given in equation (3).  
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Hydrolysis products of TPGS are: 
 
TPGS   α-TS + PEG                                                                    (1) 
    
α-TS   α-TOH + S                                                         (2) 
 
TPGS    α-TOH + S + PEG              (3) 
 
Free Radicals 
Free radicals are usually highly reactive chemical species carrying an odd, 
unpaired electron in their valence shell11. They are generally unstable, short-lived, and 
capture an electron from another molecule to achieve stability. The molecule that loses its 
electron becomes a free radical itself, beginning a chain reaction. In vivo, free radicals 
can react with lipids, proteins, carbohydrates, and DNA. Damage caused by these 
reactions has been associated with the pathophysiology of several diseases such as 
cancer, arthritis, aging, and heart disease12, 13, 14.     
 Oxyradicals result from the reduction of molecular oxygen11. Reduction is a gain 
of electron(s) by a chemical species while oxidation is a loss of electron(s). The 
conversion of O2 to H2O involves a total gain of 4 electrons as depicted by the scheme in 
Figure 3.  Intrinsically, the use of oxygen by aerobic organisms is associated with the risk 
of oxygen free radicals generation11. Normal metabolic processes within the body 
(endogenous sources) that generate free radicals include phagocytosis, cell respiration, 
and oxygen transport between lungs and tissues. Exogenous sources of free radicals 
include ionizing radiations from industrial exhausts, sunrays, environmental pollutants 
such as ozone, and tobacco11. Common examples of oxygen-derived damaging species 
are given in Table 1. 
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. 
Figure 3.  Reduction of molecular oxygen to water. It proceeds through steps that produce 
oxyradicals or their precursors. 
 
Table 1: Examples of oxygen-derived damaging species.  
 
 
 
 
 
Radicals Name Non-radicals Name 
O2•− Superoxide radical H2O2 Hydrogen Peroxide 
HO• Hydroxyl radical 1O2 Singlet oxygen 
ROO• Peroxyl radical HOCl Hypochlorous acid 
HO2• Hydroperoxyl radical LOOH 
Lipid 
hydroperoxide 
LO2• Lipid peroxyl radical O3 Ozone 
3εg 3Ο2 + νh ∆
1
g
1Ο2 + 1 e-
triplet oxygen singlet oxygen
∆1 g 1Ο2 + 1e- O2
Superoxide
O2 + 1e- + 2H+ H2O2
Hydrogen peroxide
H2O2 + e- + H+1 HO H2O+
Hydroxyl radical
HO + e- + H+1 H2O
Water
O2 + e-4 + 4H+ 2H2O
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Oxidative Stress and Antioxidants 
Oxidative stress is a physiological state that occurs when the generation of 
reactive oxygen species in a system exceeds the systems ability to neutralize and 
eliminate them15. Oxidation of various cellular components including DNA, lipids, and 
carbohydrates can lead to DNA damage, mitochondrial malfunction, cell membrane 
damage, and eventually cell death16. To suppress excessive oxyradicals and insure that 
tissues and metabolic processes can function properly, antioxidants are required. 
Antioxidants are substances that, when present in small amounts, inhibit reactions 
promoted by oxygen and/or free radicals. Antioxidants operate through four routes17, 18: 
 
a) They break chain reactions: alpha-tocopherol breaks lipid peroxidation 
b) They decrease the concentration of reactive oxygen species : Glutathione 
peroxidase is an enzyme that removes H2O2  and lipid hydroperoxides ( LOOH) 
as shown below: 
 
 
 
 
 
c) They scavenge initiating radicals. Superoxide dismutase (SOD) traps 
superoxide radicals as shown below: 
 
2 O2- + 2H+                         3O2 + H2O2 
                                2H2O + O2    H2O2 
 
d) They chelate transition metal catalysts. Ascorbic acid binds to transition metals. 
 
H2O2   + 2GSH    2H2O   + GSSG 
 
LOOH   + 2GSH                 LOH   + H2O   + GSSG 
  GSH: Reduced glutathione          GSSG: Oxidized glutathione 
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Natural antioxidants include enzymes like catalase, glutathione peroxidase, 
superoxide dismutase (SOD), and glucose oxidase19. Vitamin E, ascorbic acid, 
carotenoids, flavonoids, and ubiquinol are other major chemical antioxidants. 
Antioxidants prepared synthetically include butylated hydroxytoluene (BHT), pyrogallol, 
and the metal chelator ethylene diamine tetra acetate (EDTA). 
         
          
          
          
          
          
          
          
          
          
          
          
     
Figure 4. Structure of EDTA. The metal ion (M) is sequestered within the complex  
thereby  preventing its redox cycling20.         
 
Figure 5. Structures of pyrogallol and BHT.
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Figure 6. Structures of some naturally occurring antioxidants.  
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Antioxidant Properties of Vitamin E 
Vitamin E compounds possess antioxidant properties due to the hydroxyl group at 
C6 of the chroman ring that can donate its hydrogen atom to terminate free radical chain 
reactions. Ones of the primary targets of free radicals in the body are polyunsaturated 
fatty acids (PUFA). They undergo a process called lipid peroxidation12, 13.  It has been 
experimentally shown that α tocopherol acts as an antioxidant by scavenging lipid 
peroxyl radicals (reaction 3 in Figure 7), which are the chain carrying species in lipid 
peroxidation. The steps involved in fatty acids autoxidation are summarized in Figure 7.  
 
 
 
Figure 7. Reaction steps in fatty acids autoxidation. 
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The initiation step (reaction 1) is the abstraction of a hydrogen atom from the bis- 
allylic methylene of a PUFA by various agents including metal ions, UV and γ-radiations, 
and synthetic radical initiators21. The subsequent reaction (reaction 2) of the fatty acid 
radical with oxygen is exceedingly fast (>109M-1s-1) and produces a fatty acid peroxyl 
radical. Chain propagation occurs when the peroxyl radical removes a hydrogen atom 
form another fatty acid molecule (reaction 3). Encounter of the peroxyl radical with a 
tocopherol molecule terminates the chain reaction (reaction 4)22. The tocopheroxyl 
radical formed is relatively stable due to the delocalization of the unpaired electron about 
the fully substituted chroman ring system23. 
 
            
Figure 8. Reaction of an α-tocopherol molecule with a fatty acid peroxyl radical.  
     
 
Figure 9. Resonance stabilization of tocopheroxyl radical. 
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The antioxidant potency of α-tocopherol is expressed by the relative rates of 
reactions (3) and (4) in Figure 7. The inhibition reaction is exceedingly fast compared to 
the propagation step. α-Tocopherol also reacts with singlet oxygen, ozone, alkoxyl 
radicals, and superoxide. It can be observed from Table 2 that the peroxyl radical has the 
lowest standard one-electron reduction potential among alkyl, alkoxyl, and peroxyl 
radicals. It is therefore the most prevalent target of Vitamin E compounds24, 25.  
 
Table 2.  Standard one electron potential reduction for different redox systems. 
   
The effectiveness of α-tocopherol as an antioxidant is further enhanced by its 
regeneration from its oxidized products. The recycling of α-tocopherol in vitro from its 
tocopheroxyl radical form, mediated by ascorbic acid and coenzyme Q, has been 
demonstrated to proceed as shown in Figures 10 and 11 below26, 27: 
 
 
Figure 10.  Regeneration of α-tocopherol mediated by L-ascorbic acid. 
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 Figure 11.  Regeneration of α-tocopherol mediated by ubiquinol. 
 
Esters of α-tocopherol have a blocked hydroxyl group and therefore do not 
exhibit antioxidant function until the attached acid is removed by esterases in the body. 
 
Cancer and Vitamin E 
In recent years, cancer has surpassed heart disease as the leading cause of death 
among people under 85 in the US. More than a million new cancer cases are expected in 
2005 with the main killer being lung cancer28. Prostate cancer and breast cancers are the 
biggest killers among men and women respectively. Previous researchers have 
investigated the role of vitamin E homologues in helping fight and eventually prevent 
cancer. 
High blood levels of α-tocopherol have been shown to cut the risk of prostate 
cancer by about 32% in clinical trials29. In other experiments, α-tocopheryl succinate 
induced apoptosis in androgen-dependent human prostate cancer (LNCaP) cells without 
any effect on normal PrEC human prostate epithelial cells30. However, to date, no study 
has been carried out on these cell lines with TPGS as a source of vitamin E.  α-
Tocopherol and α-tocopheryl succinate being two hydrolysis products of TPGS suggests 
the effects of this compound on cell lines are worthwhile investigating. In our study, the 
comparative toxicity and uptake of TPGS and α-tocopheryl succinate on RAW 264.7 
macrophages and LNCaP cells were investigated.  
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Cell Viability Assays and Cell Death 
Cell viability measurements are used to assess the number of healthy cells in a 
sample. This can be done either by counting the number of healthy cells directly using a 
hemocytometer or by measuring an indicator of cell growth. Two parameters are usually 
considered: metabolic activity or cell membrane integrity. An increase in cell viability 
indicates cell growth, whereas a decrease in viability might be a sign of a toxic substance 
or inadequate culture conditions.   
Mitochondrial activity in cell populations was measured using   3-(4, 5-
dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT). This is a salt that is 
reduced to blue-black formazan crystals in the mitochondria of live cells. It is therefore a 
measure of cell viability. Formazan crystals dissolve upon addition of an organic solvent 
like dimethyl sulfoxide (DMSO) to form a deep purple solution that absorbs light at 575 
nm. Figure 12 shows the chemical structure of MTT. 
Dye exclusion assays take advantage of the ability of live cells with an intact 
cytoplasmic membrane to retain or exclude some dyes. The live cells population in 
samples was measured using a fluorophore called 5, 6-carboxyfluorescein diacetate 
(CFDA). This uncharged molecule penetrates into cell membranes and is converted in 
live cells by esterases to 5, 6-carboxyfluorescein, which as a dianion, is membrane 
impermeant. Only cells with intact plasma membranes retain the hydrolyzed form of the 
dye therefore accounting for the number of live cells. Carboxyfluorescein emits green 
fluorescence at wavelength 520 nm when excited at 485 nm. 
Dye-exclusion assays can also be used to determine the population of dead cells 
in a sample. Propidium iodide (PI) is a membrane-impermeant dye that penetrates only 
into cells having a damaged plasma membrane and produces a red fluorescence upon 
binding to double-stranded nucleic acids and excitation at 485nm. It is completely 
excluded by live cells. The fluorescence signal emitted at 650 nm is directly proportional 
to the number of dead cells. 
Cell death can occur by either of two distinct mechanisms: necrosis or apoptosis. 
Apoptosis sometimes referred to as programmed or normal cell death is the 
physiological process by which unwanted or useless cells are eliminated during growth 
and other normal biological processes. Necrosis, in contrast, occurs when cells are 
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exposed to extreme variance from physiological conditions, which may result in damage 
to the plasma membrane. It is therefore referred to as accidental cell death. 
 
 
 
 
 
Figure 12.  Chemical structure of 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium 
bromide (MTT). 
 
 
Figure 13.  Chemical structure of propidium iodide (PI). 
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Figure 14.  Structures of 5, 6-carboxyfluorescein diacetate and 5, 6-carboxyfluorescein. 
 
Theory of High Performance Liquid Chromatography Operation 
High performance liquid chromatography (HPLC) with electrochemical detection 
was used to measure α-tocopherol in samples. Chromatography is an analytical technique 
used to separate the components of a mixture based on their interaction with a stationary 
phase and a mobile phase. HPLC uses a liquid mobile phase (eluent) to carry the analytes 
through a column packed with a stationary material (adsorbent). The higher versatility of 
HPLC over other chromatographic techniques lies in the variety of eluents and absorbents 
that can be used31. In adsorption chromatography, the active sites of the adsorbent 
interact with the functional groups of the analytes by noncovalent bonds, nonpolar 
interactions, Van der Waals forces, and hydrophobic interactions. Compounds less tightly 
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bound are eluted out by the mobile phase earlier and effective separation of classes of 
compounds can be achieved. There are two modes of adsorption chromatography based 
on the polarity of the phases: normal phase chromatography which uses a strongly polar 
adsorbent and a nonpolar mobile phase. The second mode is reversed-phase 
chromatography in which it is the inverse31. 
In our study, reversed-phase chromatography was used and the internal standard 
was rac-5, 7-dimethyltocol (5, 7- DMT). An internal standard is a known amount of a 
compound, different from the analyte, which is added to the unknown31. Signal from the 
unknown is compared with that from the internal standard to find out how much analyte 
is present. Rac-5, 7-dimethyltocol was used as internal standard because its 
chromatographic and oxidation properties are similar to those of tocopherols. Figure 15 
shows the structure of 5, 7-DMT. 
Electrochemical detection was chosen as the detection method because it responds 
to electroactive substances and has high selectivity and sensitivity (picogram to 
femtogram level) 31. The compound of interest is either oxidized (reduced) at a specific 
potential and the current (amperes) is proportional to the analyte concentration. When 
only a small fraction of the sample (5 to 15%) is oxidized (reduced) the detector is 
referred to as an amperometric detector. However, the entire sample can be oxidized 
(reduced) so that the signal is proportional to the total amount of the analyte in the 
injected sample. This type of detector is called coulometric and is generally more 
sensitive and stable than amperometric detection31. A diagram representing the main 
components of the HPLC system is shown in Figure 16. 
 
 
Figure 15.  Chemical structure of rac-5, 7-dimethyltocol. 
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 Figure 16.  Components of the HPLC system. PF stands for prefilter31. 
  
The constant flow pump delivers the mobile phase to the pre-filter where 
particulate impurities are removed. The pressure damper compensates for the pulsations 
in the eluent due to the pump action. The guard cell oxidizes (reduces) any 
electrochemically active material from the mobile phase. This reduces background 
current and baseline noise hence maximizing the sensitivity of the detector. The sample 
can be introduced into the mobile phase, without depressurizing the system, with the use 
of a microliter syringe and a loop-type injection valve. The detector emits a response due 
to each component eluting from the column and signals a peak on the chromatogram31. 
 In a sample containing rac-5, 7-dimethyltocol and α-tocopherol, the former elutes 
first because of its greater polarity. A sample of chromatogram showing the eluting 
positions of 5, 7-DMT and α-tocopherol in reversed-phase HPLC is represented in Figure 
17. 
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Figure 17.  The elution order of rac-5, 7- DMT and α-tocopherol in reversed phase 
HPLC. 
A Para-Hydroxyanilide Derivative of RRR-α-Tocopheryl Succinate: p-HATS 
The last part of this study focused on the investigation of some critical properties 
of a compound referred to as p-HATS, which stands for para-hydroxyanilide of RRR-α-
tocopheryl succinate. It has a molecular weight of 639 g/mol and is soluble in ethanol. 
The chemical structure of p-HATS is shown in Figure 18. 
 
 
Figure 18. Chemical structure of p-HATS. 
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It can be noted from the structure in Figure 18 that the PEG 1000 end that exists 
in TPGS is replaced by para-hydroxyaniline. This makes p-HATS a very polar 
compound compared to TPGS. p-HATS also has a free hydroxyl group. Therefore, unlike 
α-TS, it is electroactive and can be detected by HPLC/ECD. This property could be used 
to measure the amount of α-TS in a sample used as a starting reagent for the synthesis of  
p-HATS. Therefore, it could be an analytical tool to determine the amount of α-TS in 
cellular systems using HPLC/ECD. The chromatographic properties of p-HATS, 
including the oxidation potential for its detection and its retention time relative to 5,7-
DMT were investigated.  
A by-product of p-HATS synthesis is para-hydroxyaniline (p-HA). Its chemical 
structure is shown in Figure 19 below. 
 
 
 
 
Figure 19. Structure of p-HA. 
 
p-HATS is a diester. Its possible hydrolysis products include p-HA, α-TS, 
succinate, and α-TOH. Therefore, in addition to its ability to be detected by HPLC/ECD, 
it might be a potential source of α-TOH. As part of this research, a solvent appropriate 
for the extraction of p-HATS was determined and an attempt was made to determine the 
products of p-HATS hydrolysis. 
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CHAPTER 2 
METHODOLOGY 
 
Reagents and Materials 
 RAW 264.7 macrophages and LNCaP cells were purchased from American Type 
Culture Collection (Manassas, VA). RPMI-1640 medium with phenol red, fetal bovine 
serum (FBS), penicillin (10,000 units/ml), streptomycin (10,000µg/ml), dimethyl 
sulfoxide (DMSO), and 1x phosphate buffer saline (PBS) were purchased from Life 
Technologies (Grand Island, NY).  TPGS was donated by Tennessee Eastman 
(Kingsport, TN), α-tocopherol succinate, α-tocopherol, p-HATS, and p-HA were 
synthesized and generously provided by Dr. John Hyatt. Rac-5, 7-dimethyl tocol was 
purchased from Matreya (Pleasant Gap, PA). Propidium iodide and 5, 6- 
carboxyfluorescein diacetate were purchased from Invitrogen Corporation (Carlsbad, 
CA). Pluronic acid, 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide 
(MTT) , Ethylene diamine tetra acetic acid (EDTA), citric acid, sodium hydroxide, 
butylated hydroxytoluene (BHT), ascorbic acid, pyrogallol, and Triton X-100 were 
purchased from Sigma Chemical Co. (St. Louis, MO). Hexane, methylene dichloride, and 
ethyl acetate were purchased from Fisher Scientific (Fair Lawn, NJ). Ethanol was 
purchased from Aaper Alcohol and Chemical Co. (Shelbyville, KY). 
 Costar 75 cm2/tissue culture flasks (sterile) and cell culture plates (sterile) were 
purchased from Costar (Cambridge, MA). Cell scrapers and pipettes were from Fisher 
Scientific (Fair Lawn, NJ).  Syringe filters, (0.22µM and 0.45 µM) purchased from 
Gelman Science (Ann. Arbor, MI). 
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Preparation of Solutions 
Cell culture medium Prepared by mixing 450 mL of RPMI-1640, 50 mL of FBS, 2.5 mL 
of a 50mg/mL penicillin/streptomycin solution.  
Polished water De-ionized water was filtered through a Sep-Pak cartridge (Water, 
Atlanta), and stored at 4ºC. 
NH4OAc/HOAc buffer (pH=4.4)  Ammonium acetate NH4OAc (38.55 g) was dissolved 
in 500 mL of polished water. The pH was adjusted to 4.4 with acetic acid (HOAc) and 
stored at 40C. 
BHT solution in hexane10ug/mL A 10.0 mg sample of BHT was dissolved in 1.0 liter 
hexane. 
Citric acid solution (3.0 mM) 0.0288 g citric acid (MW=192.1 g/mol) was dissolved in 
polished water and diluted to a final aqueous volume of 50 mL and stored at 40C. 
Mobile phase used in HPLC/ECD An 80.0 mL aliquot of 1M NH4OAc/HOAc buffer 
(pH=4.4) was mixed with 4.0 mL of 3.0 mM citric acid and polished water was added to 
give a final volume of 400 mL. The mixture was filtered through a 0.22 µM filter 
Millipore then mixed with 3600 mL of MeOH. 
Mobile phaseLite polished water (400.0 mL) was filtered through a 0.22 um filter 
Millipore then mixed with 3600 mL of HPLC grade MeOH. 
Solution of BHT (220.36 g/mol) in 100% ethanol A mass of 0.0025 g BHT was dissolved 
in 100 mL of ethanol. 
Ascorbic acid (176.1g/mol) solution: Prepared by dissolving 0.75 g in 5 mL of distilled 
water. 
Pyrogallol (126.1 g/mol) solution: Prepared by adding 1.25 g of solid pyrogallol to 5 mL 
of ethanol. 
Saturated KOH solution: KOH (14.508 g) was added to 10 mL of de-ionized water at 
room temperature. 
Alpha-tocopheryl succinate (α-TS) stock solution: A mass of 0.0008 g α-TS (530.79 
g/mol) was dissolved in 20 mL of ethanol. 
Solutions of 5, 7-dimethyltocol: Working solutions were prepared from a 0.20 µM stock 
solution by dilution with ethanol.  
Alpha-tocopherol solutions: A 10 mM stock solution was diluted with ethanol. 
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TRIS solution (0.2 M): A mass of 2.42 g was dissolved in 100 mL of  distilled H2O. 
Triton X-100 solution (2% w/v): Prepared by dissolving 0.2 g of triton X-100 in 10 mL 
of distilled water. 
EDTA tetra sodium (MW 380.2 g/mL) solution (1 M): Prepared by adding 3.80 g of 
EDTA to 10 mL of distilled water. 
TPGS solutions: A stock solution (99.14 µM) was prepared by dissolving 0.0075 g of 
TPGS (1513 g/mol) in 50 mL of boiling culture medium then the mixture was stirred for 
2 hours and filtered though a 0.22uM filter. Working solutions were prepared by diluting 
the stock solution with culture medium. 
Lysis buffer: A 10x solution was prepared by adding 20 mL of 0.2 M HCl and 25.0 mL 
of 0.2 M TRIS to a 50 mL graduated cylinder. Then, 2.5 mL of 2% triton X-100, 0.5 mL 
of 1 M EDTA solution, and 2.925 g of NaCl were added to the cylinder and the pH 
adjusted to 7.5.  The total volume was brought to 50.0 mL with deionized water and the 
mixture filtered (Nalgene # 122-0045; 115 mL top bottle, 0.45 um pore size) and stored 
in 10 mL plastic bottles at 200C.  Prior to use, the lysis buffer was diluted 10-fold with 
deionized water. 
PI solutions:  A 1mg/ml stock solution was diluted with cell culture medium to the 
required working concentrations. 
CFDA solutions: A 20% w/v Pluronic F-127/ DMSO solution was prepared by diluting 
200 µg of Pluronic F-127 in 800 µL anhydrous DMSO and the solution was warmed 
gently at ~ 400C.  To 500 µL of this mixture, 0.5 mg of CFDA (460 g/mol) was added. 
The final 2.17 mM stock solution was stored in molecular sieves. 
MTT solutions: A 2.5 mg sample of MTT (335.43g/mol) was dissolved in 5 mL culture 
medium. 
p-HATS solutions: A stock solution was prepared by dissolving 0.0016 g of solid p-
HATS (639 g/mol) in 10 mL of ethanol. This was then diluted with ethanol for lesser 
concentrations. 
p-HA solution: Prepared by dissolving 0.0025 g of solid p-HA (100 g/mol) in 10 mL of 
ethanol. 
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Methods 
All cell lines were cultured in sterile flasks at 370C in a humidified incubator with 
95% air and 5% CO2.  After reaching confluence, they were seeded either in 96-well 
plates for cell viability studies or in 12-well plates for uptake analyses.  
1. Cells were counted using a hemocytometer. They were then seeded into plates and 
incubated overnight. 
2. Culture medium was removed and the vitamin E homologue (either TPGS or α-TS) 
working solution(s) added to the cells. Vitamin E solutions of different 
concentrations were used in dose-dependent experiments, at a single time-point. 
Different incubation periods were considered as a single concentration for time-
dependent studies. 
Cell Viability Assays 
The three viability assays (PI, CFDA and MTT) were performed according to the 
scheme represented in Figure 20.  
 
 
 
Figure 20. Experimental Design in Cell Viability Study. 
CELL VIABILITY ASSAYS 
CELL CULTURE CONDITIONS
 Cell counting 
 Treatment with Vitamin E
PI CFDA MTT
RAW 264.7 macrophages, LNCaP cells 
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Dyes Addition. After incubation with the vitamin E homologue solution(s), dyes 
were added. For each experiment all three assays were conducted in the same 96-well 
plate. Fluorescence was measured in PI and CFDA assays using a Fluostar Galaxy 
Microplate Reader from BMG Labtechnologies in the standard fluorescence 
configuration using bottom-bottom optics modes. Absorbance of samples was measured 
in MTT assays using a SpectraMax 190 Microplate Reader from Molecular Devices. 
Figure 21 shows the layout adopted for dose-dependent measurements. 
 
BBBBBBBB
SSSSC4C4C4C4C3C3C3C3
C2C2C2C2C1C1C1C1CCCC
SSSSC4C4C4C4C3C3C3C3
C2C2C2C2C1C1C1C1CCCC
SSSSC4C4C4C4C3C3C3C3
C2C2C2C2C1C1C1C1CCCC
MTT
CFDA
PI  
Figure 21. Layout of the 96-well plate in dose-dependent cell viability assays. The wells 
are labeled according to their contents. C: non-treated cells in culture medium, used as 
control.C1, C2, C3, and C4 are increasing concentrations or vitamin E homologues. S: 
cells treated with staurosporine, used as negative control. B: cells in medium that were 
not treated with a fluorophore, used as blank. 
For time-dependent assays, slight modifications of the above layout were used. 
All wells contained cells treated with the same concentration of vitamin E.  Increasing 
time points were represented as T1, T2, and T3.  The blank used was the same as 
previously. Figure 22 shows the plate layout used in time-dependent experiments. 
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T3T3T3T3T2T2T2T2T1T1T1T1
T3T3T3T3T2T2T2T2T1T1T1T1
T3T3T3T3T2T2T2T2T1T1T1T1
MTT
CFDA
PI  
Figure 22.  Plate layout in time-dependent experiments. 
PI Assay.  A 100 µL aliquot of 3 µM PI was added to each well to give a final 
volume of 200 µL and a 1.5 µM PI concentration. The cells were incubated for 10 
minutes with PI then the fluorescence measured (excitation 485nm/emission 650 nm). 
CFDA Assay.  Medium was first removed and cells washed three times with 1x 
PBS. A 100 µL aliquot of 1.1 µM CFDA was added to each well. After incubating for 10 
minutes, fluorescence was measured (excitation 485 nm/emission 520 nm). 
MTT Assay.  Medium was first removed and 100 µL of the 0.5mg/mL MTT 
solution added to each well. Cells were incubated for 30 minutes for formation of blue 
formazan crystals. MTT was carefully removed from each well without disturbing the 
crystals and a 100 µL volume of DMSO added to dissolve them. Absorbance was 
measured at 570 nm after 30 minutes.  
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Cellular Uptake and Hydrolysis of TPGS and α-TS   
An analytical method was devised to measure cellular uptake and hydrolysis of 
TPGS. Experiments were carried out using TPGS-treated cells and also with α-TS-
treated cells. The experimental design used in this part of the study is shown in Figure 23. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 23. Diagram of experimental design for measurement of cellular tocopherol 
content. 
1. Cell Culture Conditions.   
2. Cell lysate Preparation. 
Addition of antioxidants (ascorbic acid, pyrogallol and EDTA) and 
ethanol to cell lysate. 
UPTAKE 
Total cellular tocopherol content 
(TPGS+ α-TS+ α-TOH) 
 
1. Addition of saturated KOH in 
the dark. 
2. Incubation for 5 minutes in a 
700C water-bath. 
3. Allow for cooling. 
 
HYDROLYSIS 
Free cellular tocopherol content 
(α-TOH) 
No addition. 
EXTRACTION 
1. Addition of hexane, distilled water and internal standard. 
2. Vortexing of each sample for 2 minutes then centrifugation for 10 minutes 
at 4000xg.  
3. Removal of a hexane layer aliquot. 
4. Drying under nitrogen. 
5. Reconstitution in mobile phase. 
6. Vortexing for 1 minute then filtration through a 0.22 µM filter. 
ANALYSIS using HPLC/ECD 
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Cell Lysate Preparation. 
1. Cells were incubated in a 12-well plate with TPGS or α-TS. Time and dose-
dependent experiments were carried out concurrently in the same well plate.  
2. The medium was removed and the cells were washed three times with 1xPBS. 
They were overlayed with 1.5 mL of lysis buffer and scraped. 
3. Cell lysate was collected in glass vials and submitted to two cycles of freezing 
and thawing. 
 
Addition of Ethanol and Antioxidants. Cell lysate from each well was equally 
divided and put in two separate vials: one for the measurement of cellular total tocopherol 
and the other for free tocopherol. In separate glass vials, for every 500 µL of cell lysate, 
500 µL of ethanol, 100 µL of ascorbic acid, 100 µL of pyrogallol, and 200 µL of EDTA 
were added. To determine the total tocopherol content, the vial contents was hydrolyzed 
with saturated KOH as outlined in figure 21.  Free tocopherol determination did not 
require any KOH hydrolysis. 
 
Extraction.  Both vials contents were then extracted into hexane. For every 500 
µL of initial cell lysate, 1 mL of hexane containing 10 µg BHT, 250 µL of distilled water 
and 250 µL of rac-5, 7- dimethyl tocol as internal standard were added to each vial. The 
mixture was then vortexed for 2 minutes on a Maxi-Mix 1 mixer from 
BARNSTEAD/THERMOLYNE (Dubuque, IA). Samples were centrifuged for 10 
minutes at 4000xg in an International Centrifuge from International Equipment Co. 
(Needham, MA). A 500 µL aliquot of the supernatant hexane layer was removed from 
each vial and dried under nitrogen. A 200 µL volume of mobile phase was then added 
and the mixture vortexed for 1 minute, filtered through a 0.22 µm syringe-driven filter 
unit from Millipore Corporation (Billerica, MA), and either analyzed directly or kept at -
200C until used. 
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Measurement of Tocopherol Content Using HPLC/ECD.  Cellular tocopherol 
content was measured using a HPLC equipped with a Coulochem II Electrochemical 
Detector, a ESA Model 580 Solvent Delivery Module, a HR-80 column(C 18, 3 µm, 8 
cm), a Model 5011 Analytical Cell, a Model 5020 Guard Cell (Chelmsford, MA), a PE 
Nelson 900 Series interface with PE Nelson Tuberchrom V4 Software (Perkin Elmer, San 
Jose, CA) using a Dell computer. Throughout the study, the flow rate was maintained at 
1.5 mL/mn with E=300 mV, E2=400 mV. E and E2 are the potential of the guard cell and 
the analytical electrode, respectively.  
 
Response Factor Determination.  To use an internal standard, a known mixture of 
standard and analyte is prepared and the relative response of the detector to the two 
species carefully measured. Because α-tocopherol was the compound to measure, it was 
used to determine the response factor relative to rac-5, 7 dimethyl tocol. Standard 
solutions of α-tocopherol and rac-5,7- dimethyl tocol were prepared and their  maximum 
absorbance wavelengths measured using a Cary 50 Bio UV-Visible Spectrophotometer 
from Varian (Walnut Creek, CA). The standard solutions were mixed and the areas under 
the peaks measured by the HPLC/ECD method. Purity of 5, 7-DMT and α-TOH 
solutions was tested using HPLC with UV detection and the correction coefficients for 
concentrations obtained. The response factor F was determined as shown below: 
 
AT = area under the peak for α-TOH 
ADMT = area under the peak for rac-5, 7- DMT 
[T] = concentration of α-TOH 
[DMT]= concentration of rac-5, 7- DMT 
 
The response factor F is given by the formula: 
 
 
AT/ [T] = F x (ADMT/ [DMT]) 
 
 
Once F is known, unknown concentrations of tocopherol can be obtained for subsequent 
sample runs, knowing [DMT], AT and ADMT. 
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[T] = (1/F) x [DMT] x (AT/ADMT) 
 
Properties of p-HATS 
Pure solutions of p-HATS were prepared in ethanol. To determine the optimal 
oxidation potential for p-HATS detection, a mixture of 250 pmol p-HATS and 79 pmol 
of 5, 7-DMT was prepared in mobile phase. HPLC/ECD was used to detect both 
compounds at different oxidation potentials.  
In order to determine a solvent suitable for the extraction of p-HATS, 500 µL of a 
25 µM solution was treated with antioxidants. 5, 7-DMT was added and the extraction 
carried out into four different solvents: hexane, methylene chloride, octane and ethyl 
acetate. HPLC/ECD then used to detect p-HATS. 
A solution of 120 pmol p-HA and 55 pmol 5, 7-DMT in mobile phase was 
prepared and analyzed using HPLC/ECD.  
Saponification of 500 µL of a 25 µM p-HATS solution was carried out in order to 
identify the products of its hydrolysis. Extraction was done using hexane and ethyl 
acetate and the compounds detected by HPLC/ECD. 
 
 
 
 
 
 
 
 
 
 - 39 - 
CHAPTER 3 
RESULTS 
Cytotoxicity of TPGS and α-TS 
 
Determination of Optimal PI and CFDA Concentrations in Cell Viability Assays 
RAW 264.7 macrophages were seeded in a 96-well plate, incubated overnight to 
adhere to the bottom of the wells, and then incubated with 2 µM staurosporine (a positive 
control) for 16 hours. The population of dead cells was then evaluated using PI solutions 
of varying concentrations (0.15, 1.50, 3.70, and 6.00 µM). Figure 24 shows the PI 
fluorescence as a function of the dye concentration. 
 
 
Figure 24. Determination of the optimum PI concentration. RAW 264.7 macrophages 
were treated with 2 µM staurosporine for 16 hours. Cell viability was then assessed using 
different concentrations of PI. * Statistically different from 0.15 µM PI and ** 
statistically different from other PI concentrations (P<0.05). Values are means ± S.E.M 
from 4 wells. 
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As shown in Figure 24, at PI concentrations above 1.50 µM, the strength of the 
fluorescence signal did not vary significantly with increasing PI concentrations. In all PI 
assays, 1.50 µM was therefore used. 
CFDA has been shown to alter cell viability at high concentrations (> 10 µM) 41. 
Therefore, in order to carry out an assay with this dye, a calibration must first be done in 
order to determine the minimum concentration that would produce high fluorescence in 
live cells.  RAW 264.7 macrophages were seeded in a 96-well plate and left overnight to 
attach to the bottom of the wells. The medium was removed and cells washed 3 times 
with serum-free medium. CFDA solutions of concentrations 0.5, 1.1, 2.2, 3.5, and 4.3 µM 
were then used to assess the population of live cells. 
 
0.5 1.1 2.2 3.5 4.3
C
FD
A
 fl
uo
re
sc
en
ce
,a
rb
itr
ar
y 
un
its
0
5000
10000
15000
20000
25000
30000
35000
 
 
Figure 25. Determination of the optimum CFDA concentration. RAW 264.7 
macrophages were seeded in a 96-well plate and left overnight to attach to the bottom of 
the wells. Cell viability was then assessed using different concentrations of CFDA. * 
Statistically different from 0.5 µM (P<0.05). Values are means ± S.E.M from 4 wells. 
CFDA concentration, µM 
*
*
* *
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It is observed from Figure 25 that, above 1.1 µM, the fluorescence signal is high 
enough to indicate live cells populations; therefore, 1.1 µM was used in all CFDA assays. 
 
Selection of Optics for Fluorescence Readings 
On the Fluostar Galaxy microplate reader used for fluorescence measurements, it 
is possible to switch from top to bottom optics through a simple optical change. Cell-
based assays are generally closer to the bottom optics, allowing more sensitive 
measurements. In order to determine the optimum optics settings in our study, a PI assay 
was carried out on cells incubated with 0.5 and 1.0 µM staurosporine for 20 hours. 
Readings from the four possible combination of optics (bottom-bottom, bottom-top, top-
top, and top-bottom) are shown in Figure 26, along with results from an MTT assay. The 
percentage of dead cells relative to untreated cells was determined using the following 
formulae: 
 
MTT assay 
% dead cells = {1- (At/Ac)} x 100 
 
PI assay  
% dead cells = {(Ft-Fc)/Fc} x 100 
 
At = Absorbance of treated cells 
Ac = Absorbance of control cells 
Ft = Fluorescence of treated cells 
Fc = Fluorescence of control cells 
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Figure 26. The percentage of dead cells after 20 hours of incubation with various 
concentrations of staurosporine. Untreated cells were used as negative control. The PI 
assay was conducted with four different optics settings of the microplate reader * 
statistically different from MTT assay results (P<0.05).  
 
The data in Figure 26 indicate a low percentage of dead cells in untreated samples 
and show a high percentage of cell death in cells treated with staurosporine. This shows 
that the assay worked well. It can be seen that the PI assay carried out with bottom-
bottom optics gives results closest to those obtained with the MTT assay. In this research, 
those fluorescence readings were therefore done with bottom-bottom settings. 
 
 
Staurosporine concentration, µM 
*
*
*
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Dose and time-dependent viability of RAW 264.7 macrophages treated with TPGS  
(a) Confluent (2x 106 cells/well) RAW 264.7 cells were seeded in a 96-well 
plate and left overnight to attach to the bottom of the wells. They were then incubated 
with TPGS-enriched medium at concentrations of 12.4, 24.8, 37.2, and 49.6 µM for 24 
hours.  Cell viability was determined using the PI, CFDA and MTT assays as shown in 
Figures 27, 28, and 29, respectively. 
 
 
Figure 27.  PI assay of RAW 264.7 macrophages viability after 24 hours of incubation 
with increasing concentrations of TPGS-enriched medium. Untreated cells and cells 
incubated with 2 µM staurosporine (stau) were used as negative and positive controls, 
respectively. * Statistically different from the negative control (P≤ 0.05). Values are 
means ± S.E.M from 4 wells.  
 
It can be observed from Figure 27 that a significant increase in the population of 
dead cells occurs when macrophages are exposed overnight to concentrations of TPGS at 
or greater than 12.4 µM.  The high population of dead cells with the staurosporine 
positive control showed that this assay worked well. 
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Figure 28.  RAW 264.7 macrophages viability after 24 hours of incubation with TPGS, as 
measured by the CFDA assay. Untreated cells and cells incubated with 2 µM 
staurosporine (stau) were used as negative and positive controls, respectively. * 
Statistically different from the negative control (P≤ 0.05). Values are means ± S.E.M 
from 4 wells. 
It is observed from Figure 28 that the CFDA fluorescence signal produced by live 
cells is significantly reduced after treatment with TPGS concentrations equal to or greater 
than 12.4 µM.  This indicates a decrease in the population of live cells. The low 
population of live cells with the staurosporine positive control confirmed the 
effectiveness of this assay.   
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Figure 29.  RAW 264.7 macrophages viability as measured with the MTT assay 
after 24 hours incubation with TPGS. Untreated cells and cells incubated with 2 µM 
staurosporine (stau) were used as negative and positive controls, respectively.  * 
Statistically different from the negative control (P≤ 0.05).  Values are means ± S.E.M 
from 4 wells. 
 
The decrease in mitochondrial activity observed in Figure 29 with increasing 
concentrations of TPGS confirms cell death is caused by TPGS concentrations ≥ 12.4 µM 
and is dose-responsive. The low population of live cells with the staurosporine positive 
control confirmed this assay worked well. 
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(b) To test for time-dependence, RAW 264.7 cells were seeded in a 96-well 
plate and left overnight to attach to the bottom of the wells and then incubated with 24.8 
µM TPGS for 0, 4, 16, and 24 hour (s). Figure 30 shows results of cell viability as 
assessed with CFDA. 
 
 
Figure 30. Time-dependent CFDA assay for RAW 264.7 macrophages viability after 
incubation with 24.8 µM TPGS. At time 0, TPGS was added to cells then withdrawn 
immediately.  * Statistically different from 0 hour (P≤ 0.05). Values are means ± S.E.M 
from 4 wells. 
As shown in Figure 30, the population of live cells decreased with increasing time 
of incubation. Significant decreases were observed at 16 hours but not at 4 hours. 
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Comparative Viability of RAW 264.7 and LNCaP Cells Treated with TPGS 
RAW 264.7 or LNCaP cells were seeded in 96-well plates and after an overnight 
incubation in medium, then they were treated with increasing concentrations of TPGS 
solutions for 24 hours. The number of live cells was assessed using the MTT assay. 
Figure 31 shows the changes observed in mitochondrial activity. 
 
Figure 31.  MTT assay of RAW 264.7 and LNCaP cells incubated with TPGS for 
24 hours.  Untreated cells and cells incubated with 2 µM staurosporine (stau) were used 
as negative and positive controls, respectively. * Statistically different from untreated 
cells (P≤ 0.05).  Values are means ± S.E.M from 4 wells. 
It can be observed from Figure 31 that there is a decrease in mitochondrial 
activity with increasing concentrations of TPGS. This indicates that cell death is dose-
dependent for both cell lines. However, a significant reduction in the number of live 
macrophages and LNCaP cells occurred after initial treatment with 12.4 and 24.8 µM 
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TPGS, respectively. The high number of cell death caused by staurosporine, the positive 
control, confirmed the reliability of this assay.    
Comparative Viability of RAW 264.7 and LNCaP Cells Treated with α-TS 
RAW 264.7 or LNCaP cells were seeded in 96-well plates and incubated 
overnight for the cells to adhere to the bottom of the well plates. They were then treated 
with increasing concentrations of α-TS-enriched medium for 24 hours. The medium was 
removed and the number of live cells assessed using the MTT assay. Figure 32 shows the 
changes observed in mitochondrial activity. 
 
Figure 32. MTT assay of RAW 264.7 and LNCaP cells incubated with α-TS for 24 
hours.  * Statistically different from the other cell line, at the same concentration (P≤ 
0.05).   ** Statistically different from untreated cells (P≤ 0.05). Values are means ± 
S.E.M from 4 wells. 
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In Figure 32, the reduction in mitochondrial activity observed with increasing 
concentrations of α -TS indicates that significant decrease in the number of live cells is 
dose-dependent for both cell lines and occurs after treatment with concentrations of α -
TS ≥12.4 µM. RAW 264.7 macrophages appear to be more sensitive than LNCaP cells 
when both are treated with the same concentration of α-TS. The low population of live 
cells with the staurosporine positive control this assay was successful. 
 
Cellular Uptake of TPGS and α-TS 
In order to identify the cause of cell death observed after incubation of RAW 
264.7 and LNCaP cells with TPGS and α-TS, the cellular uptake and hydrolysis of these 
α-tocopheryl esters was measured using HPLC/ECD as described in the Methods 
Section. Cells were grown then seeded in 12-well plates.  They were then incubated with 
TPGS or α-TS-enriched medium to allow the cellular uptake and hydrolysis. Lysis buffer 
was then added to break up the cell membranes and release any cellular tocopherol, 
which was then extracted in hexane and measured using HPLC/ECD. The uptake was 
measured as total tocopherol whereas free α-tocopherol indicates cellular hydrolysis of 
the esters. In these experiments, untreated cells were used as a control. 
 
Dose-Dependent Uptake and Hydrolysis of TPGS and α-TS 
RAW 264.7 or LNCaP cells were incubated with either TPGS or  α-TS of 
concentrations 24.8 or 49.6 µM TPGS for 24 hours. The amounts of free and total 
tocopherol recovered from TPGS are shown in Figures 33 and 34, respectively. 
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Figure 33.  Cellular concentration of free tocopherol after 24 hours incubation with 
TPGS. Each well contained 1 mL of TPGSenriched medium and after incubation, 
medium removal and cell washing, 1.5 mL of lysis buffer were added.  α-Tocopherol 
from the cell lysate was then extracted into hexane and measured using HPLC/ECD. 
Lysate from untreated cells was used as control.  Values are means ± S.E.M from two 
experiments. * Statistical difference from the other cell line P<0.05. 
 
As shown in Figure 33, a significant difference was observed between the levels 
of free tocopherol from the hydrolysis of TPGS by RAW 264.7 macrophages and that by 
LNCaP cells.  
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Figure 34.  Cellular concentration of total tocopherol in RAW 264.7 and LNCaP cells 
after 24 hours incubation with TPGS. Each well contained 1 mL of TPGSenriched 
medium and after incubation, medium removal and cell washing, 1.5 mL of lysis buffer 
were added. α-Tocopherol from the cell lysate was then extracted into hexane and 
measured using HPLC/ECD.  Lysate prepared from untreated cells was used as control. 
Values are means ± S.E.M from two experiments. * Statistically different from the other 
cell line, at the same TPGS concentration (P≤ 0.05).  
 
The uptake of TPGS by RAW 264.7 macrophages was found to be greater than 
that observed for LNCaP cells (see Figure 34). The amounts of total tocopherol decreased 
with that of TPGS increasing because higher TPGS concentrations also cause more cell 
death. 
The intracellular uptake (pmol/well) and hydrolysis of α-TS by RAW 264.7 and 
LNCaP cells, after a  24 hour incubation are shown in Figures 35 and 36, respectively. 
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Figure 35.  Cellular concentration of total tocopherol after 24 hours of incubation with α-
TS.  Each well contained 1 mL of α-TSenriched medium. After the incubation, the 
medium was removed, the cells washed and 1.5 mL of lysis buffer were added. α-
Tocopherol from the cell lysate was extracted into hexane and measured using 
HPLC/ECD. Values are means ± S.E.M from two experiments. * Statistically different 
from the other cell line, at the same α-TS concentration (P≤ 0.05). 
 
As shown in Figure 35, the cellular total tocopherol was shown to increase with 
increasing concentration of α-TS.  RAW 264.7 macrophages took up significantly greater 
amounts of α-TS than LNCaP cells. 
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Figure 36.  Cellular concentration of free tocopherol after 24 hours incubation with α-TS. 
After 24 hours of incubation with α-TS, the medium was removed, the cells washed, and 
1.5 mL of lysis buffer were added per well. Cellular α-tocopherol was then extracted into 
hexane and measured using HPLC/ECD. Values are means ± S.E.M from two 
experiments. * Statistically different from the other cell line, at the same α-TS 
concentration (P≤ 0.05). 
 
As shown in Figure 36, the levels of free tocopherol decreased with increasing 
concentrations of α-TS. RAW 264.7 macrophages took up significantly greater amounts 
of α-TS than did LNCaP cells. 
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Table 3.  Percentages of cellular tocopherol recovered in dose-dependent 
experiments. RAW 264.7 macrophages and LNCaP cells were incubated for 24 hours 
with 24.8 and 49.6 µM TPGS and α-TS. Values are means ± S.E.M from two 
experiments. 
 
 
 
Table 3 shows that the percentages of free tocopherol from intracellular 
hydrolysis of TPGS and α-TS are very small compared to the levels of TPGS and/or α-
TS. It can be also observed that, whereas the percentages of esterified tocopherol 
significantly increase with the concentration of α-TS, the reverse is obtained for free 
tocopherol. The percentages of tocopherol from TPGS did not appear to follow any 
pattern.  The data in Table 4, below, indicate that only a small amount of tocopherol is 
taken up by cells (intracellular). Most of the TPGS or α-TS added per well remains in the 
culture medium. 
 
TPGS, µM α-TS, µM  
24.8 49.6 24.8 49.6 
Esterified  tocopherol, 
% 
TPGS and/or α-TS 
97.3 98.7 93.9 98.2 
RAW 264.7 
macrophages 
Free α−ΤΟΗ,% 
2.7 1.3 6.1 1.8 
Esterified tocopherol, 
% 
TPGS and/or α-TS 
96.9 95.7 82.4 100 
LNCaP cells 
Free α−ΤΟΗ,% 
3.1 4.3 17.6 0.0 
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Table 4. Concentrations of intracellular and extracellular tocopherol in pmol/well. 
 
 
Time-dependent uptake and hydrolysis of TPGS 
RAW 264.7 and LNCaP cells were incubated with 24.8 µM TPGS for 24, 48, and 
72 hours.  
Table 5.  Percentages of cellular tocopherol recovered in time-dependent 
experiments. RAW 264.7 macrophages and LNCaP cells were incubated with 24.8 µM 
TPGS for 24, 48, and 72 hours. Values are indicated as ± S.E.M from two experiments. 
 
 
 
 
TPGS,  pmol/well α-TS,  pmol/well  Tocopherol, 
Pmol/well 24800  49600  24800  49600  
Intracellular  5.63 5.36 3.45 10.26 RAW 264.7 
macrophages Extracellular 24794.37 49594.64 24796.55 49589.74 
Intracellular  3.3 2.04 0.39 5.59 
LNCaP cells 
Extracellular 24796.7 49597.96 24799.61 49594.41 
 TPGS  
Time, hours 24 48 72 
Esterified tocopherol, % 
TPGS/ α-TS 
97.3 97.0 95.7 
RAW 264.7 
macrophages Free α−ΤΟΗ,% 2.7 3.0 4.3 
Esterified tocopherol, % 
TPGS/ α-TS 
96.9 97.1 96.9 
LNCaP cells 
Free α−ΤΟΗ,% 
3.1 2.9 3.1 
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The data in Table 5 show that, unlike LNCaP cells, RAW 264.7 macrophages take 
up and hydrolyze TPGS in a time-responsive manner.  This is most likely because 
macrophages contain higher levels of esterases.  
 
Concentration Calibration Curves of α-TOH and 5, 7-DMT 
In order to establish a relationship between optical density and concentration of 
standard solutions, six solutions of α-TOH and 5, 7 DMT were prepared in ethanol and 
their absorbance measured using a Cary 50 Bio UV-Visible spectrophotometer. A scan 
was performed with baseline correction from 200 nm to 350 nm. The maximum 
absorbance at 292 nm was recorded. Beers law and molar extinction coefficients (ε = 
3460 and 3270 cm-1M-1 for 5, 7-DMT and α-TOH, respectively) were then used to 
calculate concentrations according to the formula: 
C = OD/ (ελ x l) 
C = Concentration in M 
OD = Optical density 
ε = Molar extinction coefficient, cm-1M-1 
l = Pathlength of measuring light beam. 
 
 [A]= stock solution; [B] = [A]/2; [C] = [A]/4; [D] = [A]/8; [E] = [A]/16; [F] = [A]/32. 
Beers law and molar extinction coefficients were then used to calculate concentrations. 
For example, 5, 7-DMT has ελ = 3460 cm-1M-1 at 292 nm. 
Solution A:  [A] = 0.75/3460 = 216.18 µM 
Solution B: [A]/2 = 0.37/3460 = 213.29 µM 
The average of these two values was calculated as [A], 
[A] = (216.18 µM + 213.29 µM)/2 = 215.04 µM 
Concentrations of solutions B, C, D, E and F were then obtained from [A]: 
[B]= 107.52 µM     [C] = 53.76 µM     [D] = 26.88 µM   [E] = 13.44 µM    [F] = 6.72 µM 
 
Concentrations of standard α-TOH solutions were calculated the same way using 
the molar extinction coefficient of 3270 cm-1M-1 at 292 nm.  
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[A]= 301.69 µM   [B] = 150.84 µM     [C] = 75.42 µM     [D] = 37.71 µM                     
[E] = 18.86 µM    [F] = 9.43 µM 
Linear curves of optical density versus concentration were then plotted as shown 
in Figures 37 and 38 and the linear relationship obtained. 
5,7−DMT:  Optical density = 0.0035 (concentration) - 0.0038 
α-TOH:  Optical density = .0032 (concentration) + 0.0082 
 
Figure 37.  Linear relationship between optical density and concentration for 5, 7-DMT.  
 
 
. 
Figure 38.  Linear relationship between optical density and concentration for α-TOH 
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Properties of p-HATS 
 
Oxidation Potential for Electrochemical Detection of p-HATS. 
p-HATS possess a free hydroxyl group and is therefore electroactive. In order to 
determine its chromatographic properties, the optimum oxidation potential for its 
detection using HPLC/ECD was found. A mixture of 250 pmol p-HATS and 79 pmol of 
5, 7-DMT was prepared in mobile phase and the peaks recorded at different oxidation 
potentials. Figure 39 shows the p-HATS peak areas obtained as a function of the 
oxidation potential used. 
 
 
 
Figure 39. Absolute peak areas of p-HATS as a function of oxidation potential. A 
solution of p-HATS and 5, 7-DMT was prepared in mobile phase and the two compounds 
detected using HPLC/ECD.  
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The data in Figure 39 show that no significant differences were found in the 
absolute areas of p-HATS as the oxidation potential was varied. Therefore, 400 mV, the 
potential used in previous experiments for the detection of α-TOH was used to analyze p-
HATS because this potential is optimal for vitamin E. 
 
Retention Time of p-HATS Relative to 5, 7-DMT. 
A solution of 417 pmol p-HATS, 2.30 pmol 5, 7-DMT and 2.42 pmol α-TOH was 
prepared in mobile phase and injected into the HPLC for analysis. Figure 40 shows the 
chromatogram obtained from this measurement. 
 
 
 
Figure 40.  Chromatogram of a mixture of p-HATS and 5, 7-DMT in mobile phase. 
 
It can be seen from Figure 40 that p-HATS is indeed electroactive and elutes from 
the column later than 5, 7-DMT and earlier than α-TOH. The absence of extra peaks 
suggests that the by-product of p-HATS synthesis, p-HA, was not present as an impurity 
in the sample. 
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Retention Time of p-HA Relative to 5, 7-DMT. 
In order to confirm that p-HA eluted at a retention time different from that of 5, 7-
DMT and p-HATS, a solution of 120 pmol p-HA and 55 pmol 5, 7-DMT in mobile phase 
was prepared and analyzed using HPLC/ECD. The peaks obtained are shown in Figure 
41. 
 
 
 
Figure 41.  Chromatogram of a solution of p-HA and 5, 7-DMT in mobile phase. 
 
The chromatogram in Figure 41 shows that p-HA elutes from the non-polar 
chromatographic column earlier than 5, 7-DMT. The position of this peak also proves the 
p-HATS synthesized was free of this by-product. 
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Extraction of p-HATS. 
The extraction of α-TOH was carried out in hexane throughout this study. It was 
therefore assumed that hexane might also be a suitable solvent for p-HATS. A solution of 
25 µM  p-HATS was prepared, treated with antioxidants as described earlier in the 
Methods Section, and extracted into hexane. Figures 42 and 43 show the chromatograms 
obtained in the mobile phase and after extraction into hexane, respectively. 
 
 
 
Figure 42.  Detector signal as a function of retention time for a solution of 750 pmol p-
HATS and 288 pmol 5, 7-DMT in mobile phase.  
 
The areas under the peaks in Figure 42 were obtained and used to calculate the 
response factor. F was found to be 0.6194± 0.0052. 
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Figure 43.  Chromatogram of a solution of  p-HATS extracted into hexane. 
 
The response factor (F=4.4906) calculated from the areas under the peaks in 
Figure 43 was significantly different from that obtained in Figure 42.  Much less p-HATS 
was recovered for the condition in Figure 43 than in Figure 42. This suggested that 
hexane is not suitable for the extraction of p-HATS.  Other solvents were therefore 
considered.  
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The chromatograms obtained after extraction of 12.5 nmol of p-HATS into octane, 
methylene chloride, and ethyl acetate are shown in Figures 44, 45, and 46, respectively. 
 
 
 
Figure 44.  Chromatogram of a solution of  p-HATS extracted into octane. 
 
Figure 44 shows that low levels of p-HATS were obtained after an extraction 
using octane. The response factor (F = 5.755) obtained was very high relative to that in 
Figure 42. Octane, as well as hexane, are straight hydrocarbon chains and have a polarity 
index of 0.00.  The amide group in p-HATS makes the compound very polar compared to 
TPGS. This is the reason why methylene chloride and ethyl acetate were also evaluated. 
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Figure 45.  Chromatogram of a solution of  p-HATS extracted into methylene chloride. 
 
When methylene chloride was used as extracting solvent, high levels of p-HATS 
were recovered. Indeed, this solvent has a polarity index of 3.1 and was shown to 
solubilize p-HATS better than hexane or octane. However, it took more than an hour to 
dry 500 µL  of the methylene chloride under nitrogen.   The response factor obtained, 
0.6489, was close to the value calculated from Figure 42. 
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Figure 46.  Chromatogram of a solution of  p-HATS extracted into ethyl acetate. 
 
As shown in Figure 46, ethyl acetate also extracted high levels of p-HATS. From 
all the solvents used, it gave a response factor (F = 0.6355) closest to the value obtained 
in mobile phase. It took only 30 minutes to dry 500 µL of the ethyl acetate layer under 
nitrogen. Therefore, compared to methylene chloride, it would be a better solvent for the 
extraction of p-HATS. 
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Hydrolysis of p-HATS. 
A 25 µM solution of p-HATS was prepared in ethanol; a 500 µL  aliquot was then 
treated with antioxidants and saponified with 300 µL of saturated KOH for 5 minutes. 
The products of  p-HATS hydrolysis  were then extracted into ethyl acetate and hexane 
and analyzed using HPLC/ECD. Figures 47 and 48 show the peaks obtained with ethyl 
acetate and hexane, respectively. 
 
 
Figure 47.  Chromatogram of a saponified solution of p-HATS after extraction into ethyl 
acetate. 
 
It can be seen from Figure 47 that, in addition to the internal standard peak, two 
compounds elute at times 8.9 and 16.6 minutes. In Figure 41, p-HA eluted approximately 
2 minutes before 5, 7-DMT. The chromatogram in Figure 40 showed that α-TOH elutes 
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about 4 minutes 5, 7-DMT. These facts suggest that p-HA and α-TOH might be 
hydrolysis products of  p-HATS .  
 
 
 
 
 
Figure 48.  Chromatogram of a saponified solution of p-HATS after extraction into 
hexane. 
 
From figure 48, it can be observed that a low amount of  p-HA eluted after 10 
minutes. This confirms the fact that it is one of the hydrolysis products of p-HATS. It 
should also be noted that the peak at 16.6 minutes is strong in both Figures 47 and 48, 
when ethyl acetate and hexane are used, respectively. Therefore, the extracting solvent 
used did not affect the recovery of the product(s).  These results also suggest that the 
compound is probably α-TOH.  
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Figure 49.  Chromatogram of a saponified solution of p-HATS after extraction into 
hexane and addition of α-TOH. 
 
To further investigate the identity of the peak at 16.6 minutes, 2.42 pmol of α-
TOH were added to a sample extracted in hexane after saponification and the mixture 
was analyzed using HPLC/ECD. The chromatogram obtained is shown in Figure 49.  The 
detector signal due to α-TOH is significantly greater than the one in Figure 48. This 
showed that, indeed, α-TOH is a hydrolysis product of p-HATS. 
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CHAPTER 4 
DISCUSSION 
 
The purpose of this research was to investigate and compare the toxicity and 
uptake of TPGS and α-TS by RAW 264.7 and LNCaP cells. Both esters are hydrolyzed 
intracellularly to produce α-TOH. α-TS is also a hydrolysis product of TPGS. Cell 
viability measured by PI, CFDA and MTT assays indicated that RAW 264.7 
macrophages are killed when exposed overnight to concentrations of TPGS at or greater 
than 12.4 µM.  LNCaP cells treated in similar experimental conditions show significant 
cell death with TPGS concentrations at or greater than 24.8 µM. However, it is noted 
from Figure 30 that both cell lines start dying when treated overnight with initial 
concentrations of 12.4 µM α-TS. Hence, 12.4 µM of α-TS would kill RAW 264.7 or 
LNCaP cells macrophages after 24 hours but 12.4 µM of TPGS would kill only RAW 
264.7 macrophages after such time. These results suggest that α-TS might be more 
cytotoxic than TPGS.  
From the results in Figure 30, it can be concluded that RAW 264.7 are more 
sensitive than LNCaP cells when both are treated for 24 hours with the same 
concentration of α-TS. This can be explained by the fact that macrophages contain high 
levels of esterases. This raises the question of the real cause of cell death observed. To 
determine whether cytotoxicity is due to TPGS and/or one of its hydrolysis products, the 
uptake and hydrolysis of TPGS and α-TS must be taken into consideration.  
α-TOH, PEG 1000, and succinate do not cause cell death42. The cytotoxic 
substances in this study are, therefore, TPGS itself, α-TS or both. Table 4 shows that the 
tocopherol taken up by cells mostly remains as TPGS and/or α-TS. Percentages of 
cellular α-TOH are very low further reinforcing the notion that free tocopherol is not 
responsible for the observed toxicity. It is shown in Figures 31-34 that macrophages take 
up more TPGS or α-TS than LNCaP cells do. This explains their cell death at lower 
initial concentrations of TPGS. It can be said from all these facts that RAW 264.7 and 
LNCaP cells treated with TPGS die due to TPGS and /or α-TS, but not α-TOH.  
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In an attempt to distinguish which one of the two esters killed cells, an anilide 
derivative of α-TS, p-HATS was considered as an analytical tool. Unlike α-TS, p-HATS 
has a free hydroxyl group and can therefore be detected using HPLC/ECD. A sample 
containing TPGS and α-TS could be used as a starting reagent in order to synthesize p-
HATS. Based on the assumption that only α-TS would react, measurement of p-HATS 
by HPLC would then give an indication of how much α-TS was in the starting material. 
This aspect was not further developed in this research; however, some critical properties 
of p-HATS were studied.  
The data in Figure 38 indicate that 400 mV, the optimal potential for detection of 
vitamin E compounds, can also be used to detect p-HATS. The chromatograms in Figures 
39 and 40 show that p-HA, 5, 7-DMT , p-HATS, and α-TOH elute from the column in 
the order   p-HA< 5, 7-DMT < p-HATS< α-TOH. 
The extraction of p-HATS in hexane, octane, methylene chloride, and ethyl 
acetate were also carried out. Hexane and octane give a very low recover of p-HATS 
compared to the mobile phase. This can be explained by the fact that the amide side chain 
in p-HATS is highly polar compared to the PEG 1000 moiety in TPGS.  Hexane and 
octane are straight hydrocarbon chains and both have a polarity index of 0.0043. 
Therefore, even though they are suitable for the extraction of TPGS and α-TS, they do 
not solubilize p-HATS at high levels. Methylene chloride and ethyl acetate are two 
compounds with polarity indexes 3.1 and 4.4, respectively. They were both found to 
extract high levels of p-HATS, as can be seen from the response factors 0.6489 and 
0.6355, respectively, compared to 0.6194 in the mobile phase. Ethyl acetate was shown to 
dry faster under nitrogen than methylene chloride and the background noise in Figure 44 
was less than the one in Figure 43. Therefore, to extract p-HATS, ethyl acetate was the 
best solvent among the four that were evaluated.  
In order to identify the hydrolysis product(s) of p-HATS, saponification of the 
ester with saturated KOH was carried out. Possible compounds include p-HA, α-TOH, 
succinate, and α-TS. The results from Figures 45 and 46 indicate that p-HA is produced 
in low amounts by the hydrolysis of p-HATS. The strong peak that elutes after 16.6 
minutes after extraction in methylene chloride or hexane is an indication that the 
compound is not highly polar. Indeed, if the amide group was still part of the compound, 
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its recovery in hexane would be low. α-TS and succinate are not electroactive species. 
These facts suggest that α-TOH might be the compound that elutes after 16.6 minutes. 
This hypothesis is further confirmed by the fact that the detector signal is increased, in 
Figure 49, when extra α-TOH is added to the saponified sample. Therefore, α-TOH is a 
hydrolysis product of p-HATS. If carried out successfully, the use of a cell extract 
containing TPGS and α-TS as a starting material in the synthesis of p-HATS would 
reveal what levels of α-TS are left in the cells and confirm whether cytotoxicity is caused 
by TPGS alone or by a combination of both esters. The toxicity and uptake of TPGS by 
normal cells remain to be addressed. 
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CHAPTER 5 
CONCLUSION 
 
This research, which included the cellular toxicity and uptake of TPGS and α-TS 
as well as critical properties of p-HATS, gave the following results:  
 
a) Overnight treatment of RAW 264.7 macrophages with TPGS concentrations 
at or greater than 12.4 µM cause cell death. LNCaP cells are killed under the same 
conditions with TPGS concentrations of at least 24.8 µM. Both cell lines start dying 
when treated overnight with at least 12.4 µM.  These data suggest that α-TS is more 
cytotoxic than TPGS. 
b) RAW 264.7 are more sensitive than LNCaP cells when treated overnight with 
similar concentrations of α-TS. 
c) When both cell lines are incubated with 24.8 µM TPGS or α-TS for 24 hours, 
higher concentrations of total tocopherol are obtained from TPGS than from α-TS. 
d) RAW 264.7 macrophages take up more TPGS or α-TS than LNCaP cells do. 
e) Cellular total tocopherol consists mainly of TPGS and/or α-TS. Very low 
levels of α-TOH are in the cell. These facts suggest that the observed cell death is due to 
TPGS and/or α-TS but not α-TOH. 
f) p-HATS is an electroactive species and can be detected effectively using 
HPLC/ECD. 
g) P-HATS can be detected using 400 mV, the oxidation potential for the 
detection of vitamin E compounds. 
h) The use of ethyl acetate as an extraction solvent gives a good recovery of p-
HATS from samples. 
i) p-HA and α-TOH are hydrolysis product of p-HATS. 
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   APPENDIX 
 
 Stereoisomers of RRR-α-Tocopherol 
 
Chemical structures of the 8 stereoisomeric forms of tocopherol are shown below: 
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Staurosporine 
This is a microbial alkaloid isolated from Streptomyces species. It has a strong 
toxic effect on the growth of various mammalian cells and, as such, was used in cell 
viability experiments as positive control. The chemical structure of staurosporine is 
shown below: 
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 Structure of staurosporine 
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